NasdaqGS:TWSTBiotechs
Is Twist Bioscience’s (TWST) AI Order Momentum Reshaping Its Core Life Sciences Investment Story?
In recent days, Twist Bioscience attracted concentrated analyst attention as Evercore ISI, Guggenheim, and Barclays all updated their views following discussions with management and sector reviews, highlighting AI-related order momentum and broader life science demand.
This cluster of analyst reactions underscores how AI-linked workflows and diagnostic tool trends are increasingly central to how the market assesses Twist’s business prospects.
Next, we’ll examine how the fresh analyst...